{"prompt": "['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'HRQOL assessments', '- Subjects will be asked to complete the COPD assessment Test (CAT) at each', 'study visit (scheduled [stable] visits and AECOPD visits).', \"- Subjects will be asked to complete the St. George's Respiratory Questionnaire\", 'for COPD patients (SGRQ-C) at each scheduled (stable) study visit (Visit 1', '[Month 0], Visit 2 [Month 6] and at Visit 3 [Month 12]).', 'Pre- and post-bronchodilator spirometry assessments will be done for all subjects at', 'Screening Visit (pre-Month 0) and at Visit 3 (Month 12).', '3.1.', 'Discussion of study design', 'The primary objective of this study is to prospectively investigate the prevalence and', 'distribution of bacteria and viruses isolated from sputum samples from moderate to very', 'severe COPD patients and at the time of AECOPD, in Asian populations. In order to', 'increase the chance that the patients will exacerbate during the study, only patients with a', 'documented history of at least 1 moderate or severe AECOPD in the previous year will', 'be recruited, as this is known to be the best predictor of AECOPD [Hurst, 2010].', 'Therefore, this study will permit an estimation of incidence of AECOPD in a COPD', 'population at increased risk of exacerbation. It will not provide a true population-based', 'incidence of AECOPD.', 'In order to study factors affecting disease progression in Asia Pacific, prospective data', 'from a relatively large cohort of COPD patients is essential. The use of electronic Diary', 'Cards to detect changes in the respiratory symptoms that define an AECOPD, the', 'standardised questionnaires and spirometry assessments will allow robust conclusions to', 'be drawn about the effects of exacerbations on decline in lung function and HRQOL.', 'EXACT PRO will be used to assess breathlessness, cough and presence of sputum, chest', 'symptoms, difficulty bringing up sputum, feeling tired or weak, sleep disturbance, and', 'feeling scared or worried about their condition. Advantages to this approach include', 'standardised data, reduced recall bias, and the potential to identify events and determine', 'resolution based on a predefined scoring algorithm [Leidy, 2011]. Standardised', 'questionnaires completed during study visits include the SGRQ-C and the CAT. The', 'SGRQ-C is designed to assess HRQOL, current health and does not specify a recall', 'period. The CAT is a simple, short, patient-completed instrument to assess HRQOL and', 'symptom burden in patients with COPD. The CAT has good internal consistency and', 'test-retest reliability, correlates strongly with the SGRQ-C, and is able to distinguish', 'between stable patients and those undergoing an AECOPD [Jones, 2012].', '19-OCT-2018', '34', '75661ebdab2e949f7a1f1bc2071b9dec72aceccf']['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', '3.1.1.', 'Detection of AECOPD', 'Occurrence of potential AECOPD will be monitored by means of electronic Diary Cards', 'which the subject will use to record his/ her morning symptoms on a daily basis. The', 'electronic Diary Cards will be programmed as to detect potential AECOPD as follows', '(based on the Anthonisen criteria [Anthonisen, 1987]):', 'Worsening of two or more of the following major symptoms for at least two', 'consecutive days: dyspnoea, sputum volume, sputum purulence (colour), OR', 'Worsening of any major symptom together with any of the following minor', 'symptoms for at least two consecutive days: sore throat, colds (nasal discharge', 'and/or nasal congestion), fever (oral temperature 37.5\u00b0C) without other cause,', 'increased cough, increased wheeze.', 'Note that: The same two symptoms do not have to be present on both days as long as at', 'least one major symptom is present on both days.', 'Each time a potential AECOPD is detected via the electronic Diary Card, the device will', 'alert the subject to contact the study site, and at the same time an alert will be sent to the', 'site so that the investigator or medically qualified individual contacts the subject to', 'determine if the alert is an AECOPD or not, and if an AECOPD visit is warranted. In', 'addition, the site should proactively follow-up all data received via the electronic Diary', 'Card and contact the subject whenever deemed necessary.', 'During the contact with the subject, the investigator or medically qualified individual will', 'determine whether the subject might actually be experiencing an AECOPD (e.g.', 'notifications that can be explained solely by increased physical activity will not be', 'considered):', 'If the investigator or medically qualified individual concludes that the subject is not', 'experiencing an AECOPD, this should be documented/ reported in the electronic', 'Diary website (StudyWorks). Please refer to study procedures manual (SPM) for', 'more details on how to perform this.', 'If the investigator or medically qualified individual concludes that the subject may be', 'experiencing an AECOPD, an AECOPD visit will be scheduled as soon as possible', 'after the onset of AECOPD symptoms as recorded in the electronic Diary Card or', 'confirmed by the subject (maximum 96 hours after onset of symptoms and, if', 'applicable, preferably before starting treatment with antibiotics). The AECOPD', 'onset date will be captured in the eCRF and additional information about severity', 'will be also collected.', '-', 'In case the AECOPD is confirmed but no AECOPD visit can take place, the site', 'should record the information in the medical records subject files, and in the', 'eCRF in medical records section and obtain all relevant information regarding', 'the AECOPD (hospital record, medical record etc.) and record this in the eCRF.', 'If the investigator concludes the subject is experiencing/continuing with the same', 'event for which a visit has been performed already, an AECOPD visit should not', 'take place. Medical treatment should be foreseen according to standard medical', 'practice outside of the study.', '19-OCT-2018', '35', '75661ebdab2e949f7a1f1bc2071b9dec72aceccf']\n\n###\n\n", "completion": "END"}